http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101068253-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 |
| filingDate | 2003-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101068253-B1 |
| titleOfInvention | Pharmaceutical composition for oral administration containing cyclosporin |
| abstract | The present invention is suitable for oral administration in the form of a homogeneous solution which forms an emulsion with a particle size of less than 5 microns when exposed to water or gastrointestinal fluid, the solution comprising: a) a pharmaceutically effective amount of cyclosporin , In particular cyclosporine A, b) a carrier medium comprising triglycerol monoesters of fatty acids having 6 to 30 carbon atoms or mixtures thereof, c) polyethylene glycols, d) hydrophilic-lipophilic equilibrium greater than 10 ( Nonionic surfactant with HLB), and e) optionally, a viscosity reducing agent, wherein the composition is substantially free of ethanol. Preferred carrier medium is triglycerol monooleate. Examples of viscosity relaxants are glycerol monocaprylate and glycerol monooleate.n n n Cyclosporin, carrier medium, nonionic surfactant |
| priorityDate | 2002-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.